DCGI approval to Zydus’ Virafin, will help in the treatment of Corona patients

Spread the love

New Delhi: To speed up the treatment of Coronavirus patients, the Drug Controller General of India (DGCI) on Friday approved the emergency use of the drug Virafin of Zydus Cadila. This medicine can be used to treat patients above 18 years of age.

Patients will be cured in 7 days

The company has claimed that 91.15 per cent of corona victims’ RT-PCR from test positive became negative in 7 days after taking the medicine. Using this helps corona patients recover quickly and complications in the advanced stage of the disease can be avoided.

Oxygen will need less

This drug was tested on about 250 patients in 25 centres in India. During this period, it has been observed that patients felt less need for supplemental oxygen on the use of Pegylated Interferon Alpha 2b. This means that this drug has been able to control respiratory distress and failure, which has been one of the biggest challenges in the treatment of Kovid-19 patients so far.


Please enter your comment!
Please enter your name here